These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12968467)

  • 1. [HIV-inhibiting activity of polyanion matrices and related substances containing adamantane and norbornene pharmacophores].
    Timofeev DI; Perminova NG; Serbin AV; Kiseleva IaIu; Nekliudov VV; Vatolin GIu; Kas'ian LI; Grebinik TS; Timofeev IV
    Antibiot Khimioter; 2003; 48(5):33-41. PubMed ID: 12968467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiviral action of membranotropic compounds modified by adamantane and norbornene pharmacophores exerted on different HIV-1 strains].
    Kiseleva IaIu; Perminova NG; liasunova OA; Timofeev DI; Serbin AV; Kas'ian LI; Egorov IuA; Grebinik TS; Timofeev IV
    Mol Gen Mikrobiol Virusol; 2005; (2):33-6. PubMed ID: 15954475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral activity of polycarboxylic substances modified by cage hydrocarbon and sulfoacid pharmacophors against cytomegalovirus infection in vitro].
    Pavlova MV; Fedorova NE; Serbin AV; Egorov IuA; Karaseva EN; Klimova EV; Kushch AA
    Antibiot Khimioter; 2008; 53(7-8):8-14. PubMed ID: 19227117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carboxy mimetic derivatives of nucleic acid polymeric backbones inhibiting human cytomegalovirus. 1. In vitro microbicidal effect].
    Serbin AV; Karaseva EN; Fedorova NE; Pavlova MV; Klimova EV; Leont'eva MV; Kushch AA
    Antibiot Khimioter; 2007; 52(11-12):8-13. PubMed ID: 19275050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of novel antiviral agents on HIV-1 replication].
    Vorkunova GK; Kalnina LB; Burshteĭn ME; Serbin AV; Rodionov IL; Pavlova MV; Bukrinskaia AG
    Vopr Virusol; 2009; 54(2):27-31. PubMed ID: 19459409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents.
    Burstein ME; Serbin AV; Khakhulina TV; Alymova IV; Stotskaya LL; Bogdan OP; Manukchina EE; Jdanov VV; Sharova NK; Bukrinskaya AG
    Antiviral Res; 1999 Apr; 41(3):135-44. PubMed ID: 10320046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation and characterization of newly designed alkylamidophospholipid analogues as anti-human immunodeficiency virus type 1 agents.
    Kucera LS; Iyer N; Morris-Natschke SL; Chen SY; Gumus F; Ishaq K; Herrmann DB
    Antivir Chem Chemother; 1998 Mar; 9(2):157-65. PubMed ID: 9875387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
    Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug.
    Teixeira C; Gomes JR; Gomes P; Maurel F; Barbault F
    Eur J Med Chem; 2011 Apr; 46(4):979-92. PubMed ID: 21345545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles.
    Kritsanida M; Mouroutsou A; Marakos P; Pouli N; Papakonstantinou-Garoufalias S; Pannecouque C; Witvrouw M; De Clercq E
    Farmaco; 2002 Mar; 57(3):253-7. PubMed ID: 11989804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV activity of N-1-adamantyl-4-aminophthalimide.
    Van Derpoorten K; Balzarini J; De Clercq E; Poupaert JH
    Biomed Pharmacother; 1997; 51(10):464-8. PubMed ID: 9863507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant phenytoinergic pharmacophores and anti-HIV activity--preliminary evidence for the dual requirement of the 4-aminophthalimide platform and the N-(1-adamantyl) substitution for antiviral properties.
    Vamecq J; Van derpoorten K; Poupaert JH; Balzarini J; De Clercq E; Stables JP
    Life Sci; 1998; 63(19):PL267-74. PubMed ID: 9806229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
    Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
    J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein promiscuity: drug resistance and native functions--HIV-1 case.
    Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
    J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
    Fattorusso C; Gemma S; Butini S; Huleatt P; Catalanotti B; Persico M; De Angelis M; Fiorini I; Nacci V; Ramunno A; Rodriquez M; Greco G; Novellino E; Bergamini A; Marini S; Coletta M; Maga G; Spadari S; Campiani G
    J Med Chem; 2005 Nov; 48(23):7153-65. PubMed ID: 16279773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structure and antiviral activity of adamantane-containing polymer preparation].
    Kozeletskaia KN; Stotskaia LL; Serbin AV; Munshi K; Sominina AA; Kiselev OI
    Vopr Virusol; 2003; 48(5):19-26. PubMed ID: 14598476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New lipophilic derivatives of AZT and d4T 5'-phosphonates.
    Shirokova EA; Jasko MV; Khandazhinskaya AL; Yanvarev DV; Skoblov YS; Pronayeva TR; Fedyuk NV; Pokrovsky AG; Kukhanova MK
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):981-5. PubMed ID: 14565326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleomycin has antiviral properties against drug-resistant HIV strains and sensitises virus to currently used antiviral agents.
    Georgiou NA; van der Bruggen T; Healy DM; van Tienen C; de Bie P; Oudshoorn M; Marx JJ; van Asbeck BS
    Int J Antimicrob Agents; 2006 Jan; 27(1):63-8. PubMed ID: 16332431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.